5th annual consortium meeting

On Friday 27/1, the consortium convened in Antwerp, after more than 2 years of virtual meetings. At this meeting, we welcomed our external scientific experts, members of the Data Safety Monitoring Board and the Stakeholder Committee and provided them with an overview of the Phase I clinical trial, which we have successfully completed. In addition, we looked ahead to the coming years, in particular the start of the Phase II trial. Again, it was a very interesting meeting.